Effexor & PPHN

Effexor & Persistent Pulmonary Hypertension of the Newborn (PPHN)

Persistent Pulmonary Hypertension of the Newborn (PPHN) is a serious life-threatening condition that occurs when a newborn’s circulatory system does not adapt to breathing outside of the womb. Studies have suggested that taking Effexor while pregnant may increase the risk of giving birth to a baby with PPHN.

While in the womb, babies receive oxygen from the placenta through the umbilical cord, largely bypassing the lungs. During this time, they are in a state of pulmonary hypertension, meaning that there is high pressure in the lung blood vessels, preventing them from getting oxygen into their bloodstream. Once the baby is born, this pressure subsides and the lungs take over for the umbilical cord as the body’s main oxygen delivery system. In babies with PPHN, the lungs retain this pressure and the blood flow continues to largely bypass the lungs.

Effexor PPHN Symptoms

The following symptoms are commonly associated with Effexor PPHN. These symptoms may resemble other conditions, so please consult your medical provider with any questions or concerns about your baby’s health:

  • baby appears ill at delivery or in first hours after birth
  • rapid breathing
  • rapid heart rate
  • cyanosis (blue coloring)
  • low blood oxygen levels while receiving 100 percent oxygen

Speak with an Effexor PPHN Lawyer

PPHN is a serious life-threatening condition that can create long-term complications. Many families whose children were diagnosed with PPHN following Effexor use during pregnancy are filing lawsuits seeking compensation for those injuries from Pfizer .

If your child suffers from PPHN after you were prescribed Effexor while pregnant and you would like to receive a free consultation with an Effexor birth defect lawyers, please fill out the form on the right or call toll-free (866) 981-4800.

-
Slice 1 BLF 2017